| Evaluation of the effect of curcumin capsules on glyburide therapy in patients with type‐2 diabetes mellitus P Neerati, R Devde, AK Gangi Phytotherapy Research 28 (12), 1796-1800, 2014 | 106 | 2014 |
| Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zinc JR Kanwar, G Mahidhara, K Roy, S Sasidharan, S Krishnakumar, ... Nanomedicine 10 (1), 35-55, 2015 | 82 | 2015 |
| Improved neuroprotective effect of resveratrol nanoparticles as evinced by abrogation of rotenone-induced behavioral deficits and oxidative and mitochondrial dysfunctions in … S Palle, P Neerati Naunyn-Schmiedeberg's Archives of Pharmacology 391, 445-453, 2018 | 72 | 2018 |
| Quercetin nanoparticles attenuates scopolamine induced spatial memory deficits and pathological damages in rats S Palle, P Neerati Bulletin of Faculty of Pharmacy, Cairo University 55 (1), 101-106, 2017 | 58 | 2017 |
| Curcumin regulates colon cancer by inhibiting P-glycoprotein in in-situ cancerous colon perfusion rat model P Neerati, YA Sudhakar, JR Kanwar Journal of cancer science & therapy 5, 313, 2013 | 58 | 2013 |
| Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition SL Edwards, V Poongavanam, JR Kanwar, K Roy, KM Hillman, N Prasad, ... Chemical communications 51 (46), 9499-9502, 2015 | 54 | 2015 |
| Study on in situ and in vivo absorption kinetics of phenytoin by modulating P-glycoprotein with verapamil in rats P Neerati, D Ganji, SK Bedada European journal of pharmaceutical sciences 44 (1-2), 27-31, 2011 | 44 | 2011 |
| Enhanced oral bioavailability of domperidone with piperine in male wistar rats: involvement of CYP3A1 and P-gp inhibition BL Athukuri, P Neerati Journal of Pharmacy & Pharmaceutical Sciences 20, 28-37, 2017 | 43 | 2017 |
| Enhanced Oral Bioavailability of Diltiazem by the Influence of Gallic Acid and Ellagic Acid in Male Wistar Rats: Involvement of CYP3A and P‐gp Inhibition PN B L Athukuri Phytotherapy Research 31 (9), 1441-1448, 2017 | 32 | 2017 |
| Effect of resveratrol on the pharmacokinetics of carbamazepine in healthy human volunteers SK Bedada, P Nearati Phytotherapy research 29 (5), 701-706, 2015 | 31 | 2015 |
| Effect of resveratrol treatment on the pharmacokinetics of diclofenac in healthy human volunteers SK Bedada, NR Yellu, P Neerati Phytotherapy research 30 (3), 397-401, 2016 | 30 | 2016 |
| Effect of diosmin on the intestinal absorption and pharmacokinetics of fexofenadine in rats P Neerati, SK Bedada Pharmacological Reports 67 (2), 339-344, 2015 | 29 | 2015 |
| The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subjects SK Bedada, P Neerati European journal of clinical pharmacology 74, 91-97, 2018 | 27 | 2018 |
| Resveratrol pretreatment affects CYP2E1 activity of chlorzoxazone in healthy human volunteers SK Bedada, P Neerati Phytotherapy research 30 (3), 463-468, 2016 | 27 | 2016 |
| Influence of atorvastatin on the pharmacokinetics and pharmacodynamics of glyburide in normal and diabetic rats P Neerati, J Gade European Journal of Pharmaceutical Sciences 42 (3), 285-289, 2011 | 27 | 2011 |
| Effect of resveratrol on the pharmacokinetics of fexofenadine in rats: Involvement of P-glycoprotein inhibition SK Bedada, NR Yellu, P Neerati Pharmacological Reports 68 (2), 338-343, 2016 | 26 | 2016 |
| Enhanced oral bioavailability of metoprolol with gallic acid and ellagic acid in male Wistar rats: involvement of CYP2D6 inhibition BL Athukuri, P Neerati Drug Metabolism and Personalized Therapy 31 (4), 229-234, 2016 | 24 | 2016 |
| Enhancement of oral bioavailability of rivastigmine with quercetin nanoparticles by inhibiting CYP3A4 and esterases S Palle, P Neerati Pharmacological Reports 69 (2), 365-370, 2017 | 20 | 2017 |
| Influence of curcumin on pioglitazone metabolism and Pk/Pd: diabetes mellitus P Neerati, M Ravi Karan, JR Kanwar J Diabetes Metab S 6, 2, 2012 | 19 | 2012 |
| Resveratrol enhances the bioavailability of fexofenadine in healthy human male volunteers: involvement of P-glycoprotein inhibition SK Bedada, SA Yakkanti, P Neerati J Bioequiv Availab 6, 158-163, 2014 | 18 | 2014 |
